Company profile for Orient EuroPharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

OEP Group, also known as Orient EuroPharma, is a multinational pharmaceutical company founded in 1982 and listed on the Taiwan Stock Exchange. The company integrates research and development, manufacturing, marketing and distribution of prescription medicines, nutrition products, healthcare supplements and dermo-cosmetics to meet real health needs. With subsidiaries across Asia and the United States, OEP collaborates with glob...
OEP Group, also known as Orient EuroPharma, is a multinational pharmaceutical company founded in 1982 and listed on the Taiwan Stock Exchange. The company integrates research and development, manufacturing, marketing and distribution of prescription medicines, nutrition products, healthcare supplements and dermo-cosmetics to meet real health needs. With subsidiaries across Asia and the United States, OEP collaborates with global partners to bring innovative, high-quality healthcare solutions to markets worldwide.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Taiwan
Address
Address
13F., No. 128, Sec. 6, Chengde Rd., Taipei 112
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

IPhEB Russia

Not Confirmed

envelop Contact Supplier

IPhEB Russia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/02/25/3244483/0/en/George-Medicines-advances-its-global-commercial-strategy-for-GMRx2-with-an-exclusive-licensing-agreement-with-Orient-EuroPharma-in-Southeast-Asia.html

GLOBENEWSWIRE
25 Feb 2026

https://www.contractpharma.com/contents/view_breaking-news/2023-03-29/oncovent-orient-europharma-enter-license-agreement-for-oregovomab/?widget=listSection

CONTRACT PHARMA
29 Mar 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty